Update on Campylobacter vaccine development
نویسندگان
چکیده
منابع مشابه
Update on progress in HIV vaccine development.
The 19th Conference on Retroviruses and Opportunistic Infections heralded the arrival of a new crop of potent, broadly neutralizing antibodies against HIV. This advance has given the entire vaccine field enormous hope that it will be possible one day to develop an antibody-based vaccine for HIV. However, substantial obstacles still exist in the induction of these antibodies by vaccination, give...
متن کاملUpdate on vaccine development for renal cell cancer
Renal cell carcinoma (RCC) remains a significant health concern that frequently presents as metastatic disease at the time of initial diagnosis. Current first-line therapeutics in the advanced stage setting include anti-angiogenic drugs that have yielded high rates of objective clinical response, however these tend to be transient in nature, with many patients becoming refractory to chronic tre...
متن کاملRecent update in HIV vaccine development
Despite the tremendous efforts to develop a successful human immunodeficiency virus (HIV) vaccine, the quest for a safe and effective HIV vaccine seems to be remarkably long and winding. Disappointing results from previous clinical trials of VaxGen's AIDSVAXgp120 vaccine and MRKAd5 HIV-1 Gag/Pol/Nef vaccine emphasize that understanding the correlates of immune protection in HIV infection is the...
متن کاملCampylobacter Update in Poultry
Campylobacter is the most common cause of diarrheal illness due to bacteria. according to the centers for Disease control and prevention (2010), over 2.4 million people are affected each year. in 2011, the cDc estimated that Campylobacter accounts for 9% of all foodborne illness, 15% of hospitalizations, and 6% of deaths. Moreover, the total basic cost of illness associated with Campylobacter i...
متن کاملDevelopment and Evaluation of CmeC Subunit Vaccine against Campylobacter jejuni.
Campylobacter jejuni is the leading bacterial cause of human enteritis in many industrialized countries. There is no commercial vaccine against C. jejuni available to date. CmeC is an essential outer membrane component of CmeABC multidrug efflux pump that plays a critical role in antibiotic resistance and in vivo colonization of C. jejuni. CmeC is prevalent in C. jejuni strains and is dramatica...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Human Vaccines & Immunotherapeutics
سال: 2018
ISSN: 2164-5515,2164-554X
DOI: 10.1080/21645515.2018.1528410